---
figid: PMC6117983__12933_2018_763_Fig4_HTML
figtitle: Platelet hyperreactivity in type 2 diabetes mellitus
organisms:
- Oryza sativa
- Olea europaea
- Theobroma cacao
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Corynephage beta
pmcid: PMC6117983
filename: 12933_2018_763_Fig4_HTML.jpg
figlink: /pmc/articles/PMC6117983/figure/Fig4/
number: F4
caption: 'Mechanisms responsible for platelet hyperreactivity in T2DM patient: Elevated
  cAMP levels leading to platelet inhibition via cAMP-dependent protein kinase (PKA),
  which disrupt signaling via receptor activation, thromboxane A2 production, MAPK
  pathway, activation of PKC. The transmembrane G-protein associated receptors involved
  are prostaglandin, P2Y, P2X, TR, and TP. Both TR and TP present novel drug targets.
  Antiplatelet drugs are shown in red. NO nitric oxide, AGE advanced glycation end
  products, RAGE AGE receptors, PKA/B/C protein kinase A/B/C, TK tyrosine kinase,
  PI-3 phosphoinositol-3 kinase, MAPK p38 mitogen-activated protein kinase, GC guanylate
  cyclase, PAR-1 protease activated receptor, TR thrombin receptor, TPα thromboxane
  receptor, TRA thrombin receptor antagonist, TPRA thromboxane receptor antagonist,
  ASA acetylsalicylic acid (aspirin)(Adapted from Kakouros et al. [])'
papertitle: 'Endothelial dysfunction and platelet hyperactivity in type 2 diabetes
  mellitus: molecular insights and therapeutic strategies.'
reftext: Raminderjit Kaur, et al. Cardiovasc Diabetol. 2018;17:121.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.925178
figid_alias: PMC6117983__F4
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC6117983__F4
ndex: 9eeb51a9-deff-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6117983__12933_2018_763_Fig4_HTML.html
  '@type': Dataset
  description: 'Mechanisms responsible for platelet hyperreactivity in T2DM patient:
    Elevated cAMP levels leading to platelet inhibition via cAMP-dependent protein
    kinase (PKA), which disrupt signaling via receptor activation, thromboxane A2
    production, MAPK pathway, activation of PKC. The transmembrane G-protein associated
    receptors involved are prostaglandin, P2Y, P2X, TR, and TP. Both TR and TP present
    novel drug targets. Antiplatelet drugs are shown in red. NO nitric oxide, AGE
    advanced glycation end products, RAGE AGE receptors, PKA/B/C protein kinase A/B/C,
    TK tyrosine kinase, PI-3 phosphoinositol-3 kinase, MAPK p38 mitogen-activated
    protein kinase, GC guanylate cyclase, PAR-1 protease activated receptor, TR thrombin
    receptor, TPα thromboxane receptor, TRA thrombin receptor antagonist, TPRA thromboxane
    receptor antagonist, ASA acetylsalicylic acid (aspirin)(Adapted from Kakouros
    et al. [])'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ager
  - Mok
  - asa
  - Arsa
  - Renbp
  - P2ry12
  - Gpr162
  - Bgn
  - Gpi1
  - Wdtc1
  - Mdga2
  - Mark2
  - Tnfrsf18
  - Pgr
  - Plat
  - Hadha
  - Psl1
  - tk
  - Irs1
  - Hspg2
  - Akt1
  - Akt2
  - ac
  - Vasp
  - Ptgs1
  - AGER
  - MOK
  - ARSA
  - P2RY12
  - GPR162
  - BGN
  - GPI
  - PGPEP1
  - IGF1
  - WDTC1
  - ATP8A2
  - MARK2
  - F2R
  - PWAR1
  - TNFRSF18
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - PGR
  - P2RX1
  - HADHA
  - PLAT
  - TK1
  - TK2
  - IRS1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - IGKV2D-19
  - AKT1
  - PTK2B
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - VASP
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - COX1
  - PTGS1
  - Gpi
  - Igf1
  - Svs4
  - F2r
  - P2ry1
  - Arachidonic acid
  - ASA
  - Cilostazol
  - Thromboxane A2
  - NO PGI
  - PGE
  - ADP
  - ATP
  - Calcium
  - 5-AMP
  - Hyperglycemia
---
